Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017. https://doi.org/10.1098/rstb.2016.0271.

Article  PubMed  PubMed Central  Google Scholar 

Shah KM, Young LS. Epstein-Barr virus and carcinogenesis: beyond Burkitt’s lymphoma. Clin Microbiol Infect. 2009;15(11):982–8.

CAS  PubMed  Google Scholar 

Ambrosio MR, Navari M, Di Lisio L, Leon EA, Onnis A, Gazaneo S, et al. The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infect Agent Cancer. 2014;9:12.

PubMed  PubMed Central  Google Scholar 

Cai X, Schäfer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006;2(3): e23.

PubMed  PubMed Central  Google Scholar 

Piccaluga PP, Navari M, De Falco G, Ambrosio MR, Lazzi S, Fuligni F, et al. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas. Oncotarget. 2016;7(1):224–40.

PubMed  Google Scholar 

Thorley-Lawson DA. EBV persistence-introducing the virus. Curr Top Microbiol Immunol. 2015;390(Pt 1):151–209.

CAS  PubMed  PubMed Central  Google Scholar 

Hatton OL, Harris-Arnold A, Schaffert S, Krams SM, Martinez OM. The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease. Immunol Res. 2014;58(2–3):268–76.

CAS  PubMed  PubMed Central  Google Scholar 

Granai M, Mundo L, Akarca AU, Siciliano MC, Rizvi H, Mancini V, et al. Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program. Infect Agent Cancer. 2020;15:28.

CAS  PubMed  PubMed Central  Google Scholar 

Scott RS. Epstein-Barr virus: a master epigenetic manipulator. Curr Opin Virol. 2017;26:74–80.

CAS  PubMed  PubMed Central  Google Scholar 

Vargas-Ayala RC, Jay A, Manara F, Maroui MA, Hernandez-Vargas H, Diederichs A, et al. Interplay between the epigenetic enzyme lysine (K)-specific demethylase 2B and Epstein-Barr virus infection. J Virol. 2019. https://doi.org/10.1128/JVI.00273-19.

Article  PubMed  PubMed Central  Google Scholar 

Leonard S, Wei W, Anderton J, Vockerodt M, Rowe M, Murray PG, et al. Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin’s lymphoma. J Virol. 2011;85(18):9568–77.

CAS  PubMed  PubMed Central  Google Scholar 

Mundo L, Ambrosio MR, Picciolini M, Lo Bello G, Gazaneo S, Del Porro L, et al. Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded MicroRNAs expression in EBER-negative Burkitt lymphoma cases. Front Microbiol. 2017;8:229.

PubMed  PubMed Central  Google Scholar 

Ambinder RF. Gammaherpesviruses and “Hit-and-Run” oncogenesis. Am J Pathol. 2000;156(1):1–3.

CAS  PubMed  PubMed Central  Google Scholar 

Birdwell CE, Queen KJ, Kilgore PC, Rollyson P, Trutschl M, Cvek U, et al. Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes. J Virol. 2014;88(19):11442–58.

PubMed  PubMed Central  Google Scholar 

Niller HH, Wolf H, Minarovits J. Viral hit and run-oncogenesis: genetic and epigenetic scenarios. Cancer Lett. 2011;305(2):200–17.

CAS  PubMed  Google Scholar 

Queen KJ, Shi M, Zhang F, Cvek U, Scott RS. Epstein-Barr virus-induced epigenetic alterations following transient infection. Int J Cancer. 2013;132(9):2076–86.

CAS  PubMed  Google Scholar 

Hutcheson RL, Chakravorty A, Sugden B. Burkitt lymphomas evolve to escape dependencies on Epstein-Barr Virus. Front Cell Infect Microbiol. 2020;10: 606412.

PubMed  Google Scholar 

Abate F, Ambrosio MR, Mundo L, Laginestra MA, Fuligni F, Rossi M, et al. Distinct viral and mutational spectrum of endemic Burkitt lymphoma. PLoS Pathog. 2015;11(10): e1005158.

PubMed  PubMed Central  Google Scholar 

Vereide D, Sugden B. Proof for EBV’s sustaining role in Burkitt’s lymphomas. Semin Cancer Biol. 2009;19(6):389–93.

PubMed  PubMed Central  Google Scholar 

Srinivas SK, Sample JT, Sixbey JW. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt’s lymphoma cell line. J Infect Dis. 1998;177(6):1705–9.

CAS  PubMed  Google Scholar 

Dittmer DP, Hilscher CJ, Gulley ML, Yang EV, Chen M, Glaser R. Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma. Int J Cancer. 2008;123(9):2105–12.

CAS  PubMed  PubMed Central  Google Scholar 

Trivedi P, Zhang QJ, Chen F, Minarovits J, Ekman M, Biberfeld P, et al. Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma. Oncogene. 1995;11(3):505–10.

CAS  PubMed  Google Scholar 

Mundo L, Del Porro L, Granai M, Siciliano MC, Mancini V, Santi R, et al. Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas. Mod Pathol. 2020;33(12):2407–21.

CAS  PubMed  PubMed Central  Google Scholar 

Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int. 2010;60(5):337–50.

CAS  PubMed  Google Scholar 

Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182–8.

PubMed  Google Scholar 

Network CGAR. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202–9.

Google Scholar 

Saha A, Jha HC, Upadhyay SK, Robertson ES. Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection. Proc Natl Acad Sci U S A. 2015;112(37):E5199–207.

CAS  PubMed  PubMed Central  Google Scholar 

Kang GH, Lee S, Cho NY, Gandamihardja T, Long TI, Weisenberger DJ, et al. DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Lab Invest. 2008;88(2):161–70.

CAS  PubMed  Google Scholar 

Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y, Hino R, et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res. 2011;71(23):7187–97.

CAS  PubMed  Google Scholar 

Ghosh Roy S, Robertson ES, Saha A. Epigenetic impact on EBV associated B-cell lymphomagenesis. Biomolecules. 2016;6(4):46.

PubMed Central  Google Scholar 

Kong D, Ma W, Zhang D, Cui Q, Wang K, Tang J, et al. EYA1 promotes cell migration and tumor metastasis in hepatocellular carcinoma. Am J Transl Res. 2019;11(4):2328–38.

CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Zhang Y, Liu M, Wang Y, Yang T, Li D, et al. TIMP2 is a poor prognostic factor and predicts metastatic biological behavior in gastric cancer. Sci Rep. 2018;8(1):9629.

PubMed  PubMed Central  Google Scholar 

Fukayama M, Kunita A, Kaneda A. Gastritis-infection-cancer sequence of Epstein-Barr virus-associated gastric cancer. Adv Exp Med Biol. 2018;1045:437–57.

CAS  PubMed  Google Scholar 

Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, et al. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer. 2006;106(7):1467–79.

CAS  PubMed  Google Scholar 

Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2012;14(1):22–9.

CAS  PubMed  PubMed Central  Google Scholar 

Takakuwa T, Luo WJ, Ham MF, Sakane-Ishikawa F, Wada N, Aozasa K. Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression. Am J Pathol. 2004;164(3):967–74.

CAS  PubMed  PubMed Central  Google Scholar 

Lay ML, Lucas RM, Ratnamohan M, Taylor J, Ponsonby AL, Dwyer DE, et al. Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye. Virol J. 2010;7:252.

PubMed  PubMed Central  Google Scholar 

Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2014;63(2):236–43.

PubMed  Google Scholar 

Re V, Brisotto G, Repetto O, De Zorzi M, Caggiari L, Zanussi S, et al. Overview of Epstein-Barr-virus-associated gastric cancer correlated with prognostic classification and development of therapeutic options. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21249400.

Article  PubMed  PubMed Central  Google Scholar 

Sanosyan A, Fayd’herbe de Maudave A, Bollore K, Zimmermann V, Foulongne V, Van de Perre P, et al. The impact of targeting repetitive BamHI-W sequences on the sensitivity and precision of EBV DNA quantification. PLoS ONE. 2017;12(8):e0183856.

PubMed  PubMed Central  Google Scholar 

Ababneh E, Saad AM, Crane GM. The role of EBV in haematolymphoid proliferations: emerging concepts relevant to diagnosis and treatment. Histopathology. 2021;79(4):451–64.

PubMed  Google Scholar 

Jox A, Rohen C, Belge G, Bartnitzke S, Pawlita M, Diehl V, et al. Integration of Epstein-Barr virus in Burkitt’s lymphoma cells leads to a region of enhanced chromosome instability. Ann Oncol. 1997;8(Suppl 2):131–5.